Indications for combined liver and kidney transplantation in children

Pediatric Transplantation

Volumn 13, Issue 6, 2009, Pages 661-669

  Chava, Srinivas P ^a   Singh, Balbir ^a   Pal, Sujoy ^a   Dhawan, Anil ^a   Heaton, Nigel D ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Combined transplantation; Kidney transplantation; Liver transplantation; Pediatric transplantation

Indexed keywords

CITRATE POTASSIUM; COBALAMIN; MAGNESIUM; PHENYLALANINE; PHOSPHATE; PYRIDOXINE; TYROSINE;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CLINICAL FEATURE; COMBINED LIVER AND KIDNEY TRANSPLANTATION; CONGENITAL DISORDER; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; GLYCOGEN STORAGE DISEASE TYPE 1; HEART FAILURE; HEMOLYTIC UREMIC SYNDROME; HEPATORENAL SYNDROME; HUMAN; KIDNEY CALCIFICATION; KIDNEY DYSPLASIA; KIDNEY FAILURE; KIDNEY PARENCHYMA; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER PARENCHYMA; LIVER TRANSPLANTATION; METABOLIC DISORDER; METHYLMALONIC ACIDEMIA; NEPHROLITHIASIS; OXALOSIS 1; PROTEIN RESTRICTION; PROTEINURIA; REVIEW; TREATMENT OUTCOME; TYROSINEMIA;

CHILD; GRAFT SURVIVAL; HUMANS; HYPEROXALURIA, PRIMARY; INCIDENCE; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; METHYLMALONYL-COA MUTASE; PEDIATRICS; TREATMENT OUTCOME;

EID: 68849125771     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01046.x     Document Type: Review

References (96)

1. Baliga P, Merion RM, Turcotte JG, et al. Preoperative risk factor assessment in liver transplantation. Surgery 1992 : 112 : 704 710.
2. Bilbao I, Charco R, Balsells J, et al. Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transplant 1998 : 12 : 123 129. (Pubitemid 128721313)
3. Lafayette RA, Pare G, Schmid CH, King AJ, Rohrer RJ, Nasraway SA. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol 1997 : 48 : 159 164.
4. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002 : 35 : 1179 1185. (Pubitemid 34454015)
5. Brown RS Jr., Lombardero M, Lake JR. Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 1996 : 62 : 1788 1793.
6. Markmann JF, Markmann JW, Markmann DA, et al. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation 2001 : 72 : 1113 1122.
7. Margreiter R, Kramar R, Huber C, et al. Combined liver and kidney transplantation. Lancet 1984 : 1 : 1077 1078.
8. Based on United Network for Organ Sharing (UNOS)/Organ Procurement Transplantation Network (OPTN). data as of January 5, 2007.
9. Simpson N, Cho YW, Cicciarelli JC, Selby RR, Fong TL. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database. Transplantation 2006 : 82 : 1298 1303.
10. Wood RP, Ellis D, Starzl TE. The reversal of the hepatorenal syndrome in four pediatric patients following successful orthotopic liver transplantation. Ann Surg 1987 : 205 : 415 419.
11. Latta K, Brodehl J. Primary hyperoxaluria type I. Eur J Pediatr 1990 : 149 : 518 522.
12. Cochat P, Deloraine A, Rotily M, Olive F, Liponski I, Deries N. Epidemiology of primary hyperoxaluria type 1. Societe de nephrologie and the societe de nephrologie pediatrique. Nephrol Dial Transplant 1995 : 10 (Suppl. 8 3 7.
13. Kemper MJ. The role of preemptive liver transplantation in primary hyperoxaluria type 1. Urol Res 2005 : 33 : 376 379.
14. van Woerden CS, Groothoff JW, Wanders RJ, Davin JC, Wijburg FA. Primary hyperoxaluria type 1 in The Netherlands: Prevalence and outcome. Nephrol Dial Transplant 2003 : 18 : 273 279.
15. Yendt ER, Cohanim M. Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria. N Engl J Med 1985 : 312 : 953 957.
16. Broyer M, Brunner FP, Brynger H, et al. Kidney transplantation in primary oxalosis: Data from the EDTA Registry. Nephrol Dial Transplant 1990 : 5 : 332 336.
17. Cochat P, Gaulier JM, Koch Nogueira PC, et al. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Eur J Pediatr 1999 : 158 (Suppl. 2 S75 S80.
18. Gagnadoux MF, Lacaille F, Niaudet P, et al. Long term results of liver-kidney transplantation in children with primary hyperoxaluria. Pediatr Nephrol 2001 : 16 : 946 950.
19. Shapiro R, Weismann I, Mandel H, et al. Primary hyperoxaluria type 1: Improved outcome with timely liver transplantation: A single-center report of 36 children. Transplantation 2001 : 72 : 428 432.
20. Hoppe B, Langman CB. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 2003 : 18 : 986 991.
21. Millan MT, Berquist WE, So SK, et al. One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: A single-center experience. Transplantation 2003 : 76 : 1458 1463.
22. Jamieson NV, European PHI Transplantation Study Group. A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): The European PH1 transplant registry experience 1984-2004. Am J Nephrol 2005 : 25 : 282 289.
23. Davis CL, Gonwa TA, Wilkinson AH. Identification of patients best suited for combined liver-kidney retransplantation: Part II. Liver Transpl 2002 : 8 : 193 211.
24. Saborio P, Scheinman JI. Transplantation for primary hyperoxaluria in the United States. Kidney Int 1999 : 56 : 1094 1100.
25. Monico CG, Milliner DS. Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria. Liver Transpl 2001 : 7 : 954 963.
26. Ellis SR, Hulton SA, McKiernan PJ, de Ville de Goyet J, Kelly DA. Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children. Nephrol Dial Transplant 2001 : 16 : 348 354.
27. Cochat P, Scharer K. Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1? Pediatr Nephrol 1993 : 7 : 212 218.
28. Nolkemper D, Kemper MJ, Burdelski M, et al. Long-term results of pre-emptive liver transplantation in primary hyperoxaluria type 1. Pediatr Transplant 2000 : 4 : 177 181.
29. Coulthard MG, Lodge JP. Liver transplantation before advanced renal failure in primary hyperoxaluria type 1. Pediatr Nephrol 1993 : 7 : 774.
30. Schurmann G, Scharer K, Wingen AM, Otto G, Herfarth C. Early liver transplantation for primary hyperoxaluria type 1 in an infant with chronic renal failure. Nephrol Dial Transplant 1990 : 5 : 825 827.
31. Horster F, Hoffmann GF. Pathophysiology, diagnosis, and treatment of methylmalonic aciduria - Recent advances and new challenges. Pediatr Nephrol 2004 : 19 : 1071 1074.
32. Kasahara M, Horikawa R, Tagawa M, et al. Current role of liver transplantation for methylmalonic acidemia: A review of the literature. Pediatr Transplant 2006 : 10 : 943 947.
33. Nyhan WL, Gargus JJ, Boyle K, Selby R, Koch R. Progressive neurologic disability in methylmalonic acidemia despite transplantation of the liver. Eur J Pediatr 2002 : 161 : 377 379.
34. Coman D, Huang J, McTaggart S, et al. Renal transplantation in a 14-year-old girl with vitamin B12-responsive cblA-type methylmalonic acidaemia. Pediatr Nephrol 2006 : 21 : 270 273.
35. Lubrano R, Scoppi P, Barsotti P, et al. Kidney transplantation in a girl with methylmalonic acidemia and end stage renal failure. Pediatr Nephrol 2001 : 16 : 848 851.
36. Nagarajan S, Enns GM, Millan MT, Winter S, Sarwal MM. Management of methylmalonic acidaemia by combined liver-kidney transplantation. J Inherit Metab Dis 2005 : 28 : 517 524.
37. van't Hoff W, McKiernan PJ, Surtees RA, Leonard JV. Liver transplantation for methylmalonic acidaemia. Eur J Pediatr 1999 : 158 (Suppl. 2 S70 S74.
38. Kayler LK, Merion RM, Lee S, et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant 2002 : 6 : 295 300.
39. Taylor CM. Complement factor H and the haemolytic uraemic syndrome. Lancet 2001 : 358 : 1200 1202.
40. Warwicker P, Goodship TH, Donne RL, et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 1998 : 53 : 836 844.
41. Ying L, Katz Y, Schlesinger M, et al. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am J Hum Genet 1999 : 65 : 1538 1546.
42. Remuzzi G, Ruggenenti P, Codazzi D, et al. Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet 2002 : 359 : 1671 1672.
43. Saland JM, Emre SH, Shneider BL, et al. Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am J Transplant 2006 : 6 : 1948 1952.
44. Remuzzi G, Ruggenenti P, Colledan M, et al. Hemolytic uremic syndrome: A fatal outcome after kidney and liver transplantation performed to correct factor H gene mutation. Am J Transplant 2005 : 5 : 1146 1150.
45. Perlmutter DH. Alpha-1-antitrypsin deficiency. In : Schiff ER, Sorrell MF, Maddrey WC, eds. Diseases of the Liver, 9th edn. Philadelphia, PA : Lippincott Williams & Wilkins, 2003 : pp. 1207 1230.
46. Loreno M, Boccagni P, Rigotti P, Naccarato R, Burra P. Combined liver-kidney transplantation in a 15-year-old boy with alpha1-antitrypsin deficiency. J Hepatol 2002 : 36 : 565 568.
47. Gartner JC Jr., Zitelli BJ, Malatack JJ, Shaw BW, Iwatsuki S, Starzl TE. Orthotopic liver transplantation in children: Two-year experience with 47 patients. Pediatrics 1984 : 74 : 140 145.
48. Bobrie G, Grunfeld JP. Nail-Patella syndrome and other rare inherited disorders with glomerular involvement. In : Davison AM, Cameron JS, Grunfeld JP, Kerr DNS, Ritz E, Winearls CG, eds. Oxford Textbook of Clinical Nephrology, 2nd edn. Oxford : Oxford University Press, 1998 : pp. 2446 2449.
49. Elzouki AN, Lindgren S, Nilsson S, Veress B, Eriksson S. Severe alpha1-antitrypsin deficiency with membranoproliferative glomerulonephritis and nephrotic syndrome, reversible after orthotopic liver transplantation. J Hepatol 1997 : 26 : 1403 1407.
50. Grewal H, Brady L, Cronin DC 2nd., et al. Combined liver and kidney transplantation in children. Transplantation 2000 : 70 : 100 105.
51. Benedetti E, Pirenne J, Troppmann C, et al. Combined liver and kidney transplantation. Transpl Int 1996 : 9 : 486 491.
52. Chou JY, Matern D, Mansfield BC, Chen YT. Type I glycogen storage diseases: Disorders of the glucose-6-phosphatase complex. Curr Mol Med 2002 : 2 : 121 143.
53. Faivre L, Houssain D, Valayer J, Brourd J, Hadchouel M, Bernard O. Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia. J Inherit Metab Dis 1999 : 22 : 723 732.
54. Chen YT. Type I glycogen storage disease: Kidney involvement, pathogenesis and its treatment. Pediatr Nephrol 1991 : 5 : 71 76.
55. Lee PJ, Muiesan P, Heaton N. Successful pregnancy after combined renal-hepatic transplantation in glycogen storage disease type I. J Inherit Metab Dis 2004 : 27 : 537 538.
56. Panaro F, Andorno E, Basile G, et al. Simultaneous liver-kidney transplantation for glycogen storage disease type IA (von Gierke's disease). Transplant Proc 2004 : 36 : 1483 1484.
57. Labrune P. Glycogen storage disease type I: Indications for liver and/or kidney transplantation. Eur J Pediatr 2002 : 161 (Suppl. 1 S53 S55.
58. Holme E, Lindstedt S. Tyrosinaemia type I and NTBC (2-(2-nitro-4- trifluoro methylbenzoyl)-1,3-cyclohexanedione). J Inherit Metab Dis 1998 : 21 : 507 517.
59. Paradis K, Weber A, Seidman EG, et al. Liver transplantation for hereditary tyrosinemia: The Quebec experience. Am J Hum Genet 1990 : 47 : 338 342.
60. Freese DK, Tuchman M, Schwarzenberg SJ, et al. Early liver transplantation is indicated for tyrosinemia type I. J Pediatr Gastroenterol Nutr 1991 : 13 : 10 15.
61. Mohan N, McKiernan P, Preece MA, et al. Indications and outcome of liver transplantation in tyrosinaemia type 1. Eur J Pediatr 1999 : 158 (Suppl. 2 S49 S54.
62. Goodman ZD, Ishak KG. Hepatic histopathology. In : Schiff ER, Sorrell MF, Maddrey WC, eds. Diseases of the Liver, 9th edn. Philadelphia, PA : Lippincott Williams & Wilkins, 2003 : pp. 69 134.
63. Di Bisceglie AM, Befeler AS. Nodular and cystic diseases of the liver. In : Schiff ER, Sorrell MF, Maddrey WC, eds. Diseases of the Liver, 9th edn. Philadelphia, PA : Lippincott Williams & Wilkins, 2003 : pp. 1149 1168.
64. McGonigle RJ, Mowat AP, Bewick M, Howard ER, Snowden SA, Parsons V. Congenital hepatic fibrosis and polycystic kidney disease; Role of porta-caval shunting and transplantation in three patients. Q J Med 1981 : 50 : 269 278.
65. De Kerckhove L, De Meyer M, Verbaandert C, et al. The place of liver transplantation in Caroli's disease and syndrome. Transpl Int 2006 : 19 : 381 388.
66. Khan K, Schwarzenberg SJ, Sharp HL, Matas AJ, Chavers BM. Morbidity from congenital hepatic fibrosis after renal transplantation for autosomal recessive polycystic kidney disease. Am J Transplant 2002 : 2 : 360 365.
67. Davis CL. Impact of pretransplant renal failure: When is listing for kidney-liver indicated? Liver Transpl 2005 : 11 (Suppl. 2 S35 S44.
68. Mention K, Lahoche-Manucci A, Bonnevalle M, et al. Renal function outcome in pediatric liver transplant recipients. Pediatr Transplant 2005 : 9 : 201 207.
69. Campbell KM, Yazigi N, Ryckman F, et al. High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation. J Pediatr 2006 : 148 : 475 480.
70. McDiarmid SV, Ettenger RB, Hawkins RA, et al. The impairment of true glomerular filtration rate in long-term cyclosporine-treated pediatric allograft recipients. Transplantation 1990 : 49 : 81 85.
71. Herzog D, Martin S, Turpin S, Alvarez F. Normal glomerular filtration rate in long-term follow-up of children after orthotopic liver transplantation. Transplantation 2006 : 81 : 672 677.
72. Wiesmayr S, Jungraithmayr T, Ellemunter H, et al. Long-term glomerular filtration rate following pediatric liver transplantation. Pediatr Transplant 2005 : 9 : 604 611.
73. Arora-Gupta N, Davies P, McKiernan P, Kelly DA. The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation. Pediatr Transplant 2004 : 8 : 145 150.
74. Kalicinski P, Szymczak M, Smirska E, et al. Longitudinal study of renal function in pediatric liver transplant recipients. Ann Transplant 2005 : 10 : 53 58.
75. Laine J, Krogerus L, Fyhrquist F, et al. Renal function and histopathologic changes in children after liver transplantation. J Pediatr 1994 : 125 : 863 869.
76. Rogers J, Bueno J, Shapiro R, et al. Results of simultaneous and sequential pediatric liver and kidney transplantation. Transplantation 2001 : 72 : 1666 1670.
77. Ruiz R, Kunitake H, Wilkinson AH, et al. Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg 2006 : 141 : 735 741.
78. Wilkinson AH, Cohen DJ. Renal failure in the recipients of nonrenal solid organ transplants. J Am Soc Nephrol 1999 : 10 : 1136 1144.
79. Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969 : 223 : 472 476.
80. Kamada N. The immunology of experimental liver transplantation in the rat. Immunology 1985 : 55 : 369 389.
81. Fong TL, Bunnapradist S, Jordan SC, Selby RR, Cho YW. Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation. Transplantation 2003 : 76 : 348 353.
82. Creput C, Durrbach A, Samuel D, et al. Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation. Am J Transplant 2003 : 3 : 348 356.
83. Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 1995 : 59 : 919 921.
84. Larue JR, Hiesse C, Samuel D, et al. Long-term results of combined kidney and liver transplantation at one center. Transplant Proc 1997 : 29 : 2365 2366.
85. Hiesse C, Samuel D, Chraibi A, et al. Combined liver and kidney transplantation in nephropathy associated with liver disease. Transplant Proc 1995 : 27 : 1262 1263.
86. Gonwa TA, Nery JR, Husberg BS, Klintmalm GB. Simultaneous liver and renal transplantation in man. Transplantation 1988 : 46 : 690 693.
87. Gutierrez A, Crespo M, Mila J, Torregrosa JV, Martorell J, Oppenheimer F. Outcome of simultaneous liver-kidney transplantation in highly sensitized, crossmatch-positive patients. Transplant Proc 2003 : 35 : 1861 1862.
88. Morrissey PE, Gordon F, Shaffer D, et al. Combined liver-kidney transplantation in patients with cirrhosis and renal failure: Effect of a positive cross-match and benefits of combined transplantation. Liver Transpl Surg 1998 : 4 : 363 369.
89. Duvoux D, Cherqui D, Schultz K, et al. Double liver-kidney transplantation in the presence of a positive T cross-match. Presse Med 1992 : 21 : 2015 2016.
90. Mosconi G, Scolari MP, Feliciangeli G, et al. Combined liver-kidney transplantation with preformed anti-HLA antibodies: A case report. Transplant Proc 2006 : 38 : 1125 1126.
91. Olausson M, Mjornstedt L, Norden G, et al. Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant 2007 : 7 : 130 136.
92. Eid A, Moore SB, Wiesner RH, DeGoey SR, Nielson A, Krom RA. Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver-kidney transplantation across a positive lymphocyte crossmatch. Transplantation 1990 : 50 : 331 334.
93. Saidman SL, Duquesnoy RJ, Demetris AJ, et al. Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol 1994 : 2 : 61 67.
94. Katznelson S, Cecka JM. The liver neither protects the kidney from rejection nor improves kidney graft survival after combined liver and kidney transplantation from the same donor. Transplantation 1996 : 61 : 1403 1405.
95. Sumimoto R, Kamada N. Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation 1990 : 50 : 678 682. (Pubitemid 20358545)
96. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992 : 339 : 1579 1582.